Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

Revisions for Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa

Primary tabs

RevisionOperations
Wed, 26/06/2019 - 12:08 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

This is the published revision.
Mon, 20/05/2019 - 21:22 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Sun, 03/03/2019 - 06:43 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Mon, 12/11/2018 - 14:43 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Wed, 07/11/2018 - 10:32 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Fri, 02/11/2018 - 23:28 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Mon, 29/10/2018 - 20:02 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Mon, 15/10/2018 - 16:28 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 20/09/2018 - 19:30 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Sun, 12/08/2018 - 15:52 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Sat, 21/07/2018 - 03:01 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Sat, 14/07/2018 - 12:25 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 05/07/2018 - 09:46 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Sat, 23/06/2018 - 19:39 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Fri, 22/06/2018 - 19:39 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Wed, 20/06/2018 - 10:44 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Tue, 05/06/2018 - 10:33 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Fri, 23/03/2018 - 12:27 by admin

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 22/03/2018 - 12:25 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 15/03/2018 - 11:33 by Anonymous (not verified)

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 15/03/2018 - 11:33 by admin

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 15/03/2018 - 11:33 by admin

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Wed, 14/03/2018 - 23:22 by admin

Update to resource 'Randomized placebo-controlled double-blind multicenter study to assess the efficacy safety and tolerability of Arikace in Cystic Fibrosis patients with chronic infection due to Pseudomonas Aeruginosa'

Thu, 08/03/2018 - 15:12 by admin